Image (Duvyzat 01)
Duvyzat Suspension
Product Images NDC 11797-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duvyzat (NDC 11797-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Italfarmaco Spa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Duvyzat 02)
Figure (Duvyzat 03)
Figure (Duvyzat 04)
Figure (Duvyzat 05)
Figure (Duvyzat 06)
Figure (Duvyzat 07)
Figure (Duvyzat 10)
Principal Display Panel (Duvyzat 11)
This text is an evaluation of medication labeled as NDC 11797-110-01, known as Duvyzat, which is an oral suspension containing givinostat. Each 1mL of the suspension comprises 886 mg of givinostat, equivalent to 10 mg of givinostat hydrochloride monohydrate. The instructions include shaking the bottle for 30 seconds before use, storing Duvyzat at room temperature between 20°C to 25°C (68°F to 77°F), and avoiding freezing. The medication guide should be provided to each patient, and the bottle should be kept tightly closed. It's important to keep the medication out of children's reach and to discard any unused Duvyzat after 60 days of first opening.*
Principal Display Panel (Duvyzat 12)
This is a product description for an oral suspension medication called Duvyzat, containing givinostat. Each 1 mL of the suspension contains 8.86 mg of givinostat. The bottle should be used within 60 days of opening and kept tightly closed. The medication is administered orally using an included oral syringe. Further instructions and dosage information can be found on the prescribing information included in the package. The product is manufactured by Italfarmaco S.A. in Madrid, Spain, and distributed by ITF Therapeutics, LLC.*
Figure (Duvyzat 8)
Figure (Duvyzat 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
